These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 22314510)
21. Retrospective study of the course, treatment and long-term follow-up of Kawasaki disease: a single-center experience from Poland. Stasiak A; Smolewska E Rheumatol Int; 2019 Jun; 39(6):1069-1076. PubMed ID: 30903369 [TBL] [Abstract][Full Text] [Related]
22. [Valvular regurgitation in patients with Kawasaki disease and in healthy children: a pulsed Doppler echocardiographic study]. Akagi T; Inoue O; Ohara N; Toyoda O; Rikitake N; Mikajima T; Suzuki K; Kato H J Cardiol; 1989 Sep; 19(3):787-96. PubMed ID: 2641773 [TBL] [Abstract][Full Text] [Related]
29. Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group. Fernandez-Cooke E; Barrios Tascón A; Sánchez-Manubens J; Antón J; Grasa Lozano CD; Aracil Santos J; Villalobos Pinto E; Clemente Garulo D; Mercader Rodríguez B; Bustillo Alonso M; Nuñez Cuadros E; Navarro Gómez ML; Domínguez-Rodríguez S; Calvo C; PLoS One; 2019; 14(5):e0215665. PubMed ID: 31107862 [TBL] [Abstract][Full Text] [Related]
30. [Clinical features and course of Kawasaki disease in central Tunisia: a study about 14 cases collected over a period of three years (2000-2002)]. Chemli J; Kchaou H; Amri F; Belkadhi A; Essoussi AS; Gueddiche N; Harbi A Tunis Med; 2005 Aug; 83(8):477-83. PubMed ID: 16238276 [TBL] [Abstract][Full Text] [Related]
31. Cardiac Valvular Lesions due to Kawasaki Disease: A Japanese Nationwide Survey. Tsuda E; Yashiro M; Nakamura Y J Pediatr; 2020 Mar; 218():78-84.e2. PubMed ID: 32089190 [TBL] [Abstract][Full Text] [Related]
32. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease. Fabi M; Andreozzi L; Frabboni I; Dormi A; Corinaldesi E; Lami F; Cicero C; Tchana B; Francavilla R; Sprocati M; Bigucci B; Balsamo C; Valin PS; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M Clin Rheumatol; 2021 Apr; 40(4):1507-1514. PubMed ID: 32936425 [TBL] [Abstract][Full Text] [Related]
33. Usefulness of echocardiographic evidence of pericardial effusion and mitral regurgitation during the acute stage in predicting development of coronary arterial aneurysms in the late stage of Kawasaki disease. Gidding SS; Duffy CE; Pajcic S; Berdusis K; Shulman ST Am J Cardiol; 1987 Jul; 60(1):76-9. PubMed ID: 3604947 [TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease? Fabi M; Corinaldesi E; Pierantoni L; Mazzoni E; Landini C; Bigucci B; Ancora G; Malaigia L; Bodnar T; Di Fazzio G; Lami F; Valletta E; Cicero C; Biasucci G; Iughetti L; Marchetti F; Sogno Valin P; Amarri S; Brusa S; Sprocati M; Maggiore G; Dormi A; Lanzoni P; Donti A; Lanari M PLoS One; 2018; 13(9):e0202658. PubMed ID: 30180185 [TBL] [Abstract][Full Text] [Related]
35. A retrospective cohort study of major adverse cardiac events in children affected by Kawasaki disease with coronary artery aneurysms in Thailand. Santimahakullert K; Vijarnsorn C; Wongswadiwat Y; Chanthong P; Khrongsrattha S; Panamonta M; Chan-On P; Durongpisitkul K; Chungsomprasong P; Kanjanauthai S; Soongswang J PLoS One; 2022; 17(1):e0263060. PubMed ID: 35085339 [TBL] [Abstract][Full Text] [Related]
36. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population. Friedman KG; Gauvreau K; Hamaoka-Okamoto A; Tang A; Berry E; Tremoulet AH; Mahavadi VS; Baker A; deFerranti SD; Fulton DR; Burns JC; Newburger JW J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633390 [TBL] [Abstract][Full Text] [Related]
37. National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA. Okubo Y; Nochioka K; Sakakibara H; Testa M; Sundel RP Clin Rheumatol; 2017 Feb; 36(2):413-419. PubMed ID: 27987089 [TBL] [Abstract][Full Text] [Related]
38. Kawasaki disease incidence in children and adolescents: an observational study in primary care. Hall GC; Tulloh LE; Tulloh RM Br J Gen Pract; 2016 Apr; 66(645):e271-6. PubMed ID: 26906631 [TBL] [Abstract][Full Text] [Related]
39. Five years of Kawasaki disease in the Netherlands: a national surveillance study. Tacke CE; Breunis WB; Pereira RR; Breur JM; Kuipers IM; Kuijpers TW Pediatr Infect Dis J; 2014 Aug; 33(8):793-7. PubMed ID: 24463809 [TBL] [Abstract][Full Text] [Related]
40. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience. Maric LS; Knezovic I; Papic N; Mise B; Roglic S; Markovinovic L; Tesovic G Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]